Malaria

Medicine

Volumn 38, Issue 1, 2010, Pages 41-46

  Walker, Naomi F ^a,b   Nadjm, Behzad ^a,b   Whitty, Christopher J M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

Anopheles; antimalarials; falciparum; knowlesi; malaria; malariae; ovale; Plasmodium; vivax

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CLINDAMYCIN; DOXYCYCLINE; FANSIDAR; PRIMAQUINE; QUININE; QUININE SULFATE;

BLURRED VISION; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; DIZZINESS; DRUG ERUPTION; EARLY DIAGNOSIS; GASTRITIS; HEALTH PROMOTION; HEARING LOSS; HEART ARRHYTHMIA; HEMOLYSIS; HUMAN; HYPOGLYCEMIA; INCUBATION TIME; LOADING DRUG DOSE; MALARIA; MALARIA FALCIPARUM; MIXED INFECTION; NAUSEA; NEUROLOGIC DISEASE; PARASITE VIRULENCE; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; TERATOGENICITY; TINNITUS; TRAVEL;

EID: 72449184142     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2009.09.017     Document Type: Review

References (15)

1. World malaria report 2008 (2008), World Health Organization. http://www.who.int/malaria/wmr2008 Available at:
2. Health protection report Vol. 2 No. 17. Available at: (April 2008). http://www.hpa.org.uk/hpr/archives/back_issues.htm
3. Smith A.D., Bradley D.J., Smith V., et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006. BMJ 337 (2008) a120
4. Chiodini P., Hill D., Lalloo D., et al. Guidelines for malaria prevention in travellers from the United Kingdom (January 2007), Health Protection Agency. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1203496943523 Available at:
5. Miller L.H., Baruch D.I., Marsh K., and Doumbo O.K. The pathogenic basis of malaria. Nature 415 (2002) 673-679
6. Nic Fhogartaigh C., Hughes H., Armstrong M., et al. Falciparum malaria as a cause of fever in adult travellers returning to the United Kingdom: observational study of risk by geographical area. QJM 101 (2008) 649-656
7. Management of severe malaria. 2nd edn. (April 2000), World Health Organization
8. Newman R.D., Parise M.E., Barber A.M., and Steketee R.W. Malaria-related deaths among U.S. travelers, 1963-2001. Ann Intern Med 141 (2004) 547-555
9. Murray C.K., Gasser Jr. R.A., Magill A.J., and Miller R.S. Update on Rapid Diagnostic Testing for Malaria. Clin Microbiol Rev. 21 (2008) 97-110
10. Lalloo D.G., Shingadia D., Pasvol G., et al. UK malaria treatment guidelines. J Infect 54 (2007) 111e121
11. Dondorp A., Nosten F., Stepniewska K., Day N., and White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Lancet 366 (2005) 717-725
12. PrayGod G., De Frey A., and Eisenhut M. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review. Malar J 7 (2008) 210-218
13. British National Formulary 57 (2009), BMJ Group and RPS Publishing, London
14. Riddle M.S., Jackson J.L., Sanders J.W., and Blazes D.L. Exchange transfusion as an adjunct therapy in severe plasmodium falciparum malaria: a meta-analysis. CID 34 (2002) 1192-1198
15. Whitty C.J.M., Edmonds S., and Mutabingwa T.K. Malaria in pregnancy. BJOG 112 (2005) 1189-1195